<article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu" aria-expanded="false">Stereotact Funct Neurosurg</button></div>. Author manuscript; available in PMC: 2023 Feb 7.</div>
<div>
<em>Published in final edited form as: </em>Stereotact Funct Neurosurg. 2022 Feb 7;100(3):168–183. doi: <a href="https://doi.org/10.1159/000521431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1159/000521431</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Stereotact%20Funct%20Neurosurg%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stereotact%20Funct%20Neurosurg%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Stereotact%20Funct%20Neurosurg%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Stereotact%20Funct%20Neurosurg%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Artifact characterization and a multipurpose template-based offline
removal solution for a sensing-enabled deep brain stimulation
device</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hammer%20LH%22%5BAuthor%5D" class="usa-link" aria-describedby="id1" aria-expanded="false"><span class="name western">Lauren H Hammer</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lauren H Hammer</span></h3>
<div class="p">
<sup>a</sup>Department of Neurology, University of California, San
Francisco, San Francisco, CA, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hammer%20LH%22%5BAuthor%5D" class="usa-link"><span class="name western">Lauren H Hammer</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kochanski%20RB%22%5BAuthor%5D" class="usa-link" aria-describedby="id2" aria-expanded="false"><span class="name western">Ryan B Kochanski</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ryan B Kochanski</span></h3>
<div class="p">
<sup>b</sup>Department of Neurological Surgery, University of
California, San Francisco, San Francisco, CA, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kochanski%20RB%22%5BAuthor%5D" class="usa-link"><span class="name western">Ryan B Kochanski</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Starr%20PA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3" aria-expanded="false"><span class="name western">Philip A Starr</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Philip A Starr</span></h3>
<div class="p">
<sup>b</sup>Department of Neurological Surgery, University of
California, San Francisco, San Francisco, CA, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Starr%20PA%22%5BAuthor%5D" class="usa-link"><span class="name western">Philip A Starr</span></a>
</div>
</div>
<sup>b,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Little%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4" aria-expanded="false"><span class="name western">Simon Little</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Simon Little</span></h3>
<div class="p">
<sup>a</sup>Department of Neurology, University of California, San
Francisco, San Francisco, CA, United States</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Little%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon Little</span></a>
</div>
</div>
<sup>a,</sup><sup>†</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>a</sup>Department of Neurology, University of California, San
Francisco, San Francisco, CA, United States</div>
<div id="A2">
<sup>b</sup>Department of Neurological Surgery, University of
California, San Francisco, San Francisco, CA, United States</div>
<div class="author-notes p">
<div class="fn" id="FN1">
<sup>†</sup><p class="display-inline" id="P1">These authors have contributed equally to this work and share senior
authorship</p>
</div>
<div class="fn" id="FN2">
<p id="P2">Author Contributions</p>
<p id="P3">LHH, PAS, and SL conceived the study. LHH and RBK collected data. LHH
processed and analyzed the data. LHH, PAS, and SL drafted the manuscript and
figures.</p>
</div>
<div class="fn" id="CR1">
<sup>✉</sup><p class="display-inline">Corresponding Author: Lauren Hammer, Department of Neurology,
University of California, San Francisco, 1651 4th St, Room 231, Box 1838, San
Francisco, CA 94143, Tel: 415-353-2311,
<span>lauren.hammer@ucsf.edu</span></p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Issue date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div>PMCID: PMC9064887&nbsp;&nbsp;NIHMSID: NIHMS1773152&nbsp;&nbsp;PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35130555/" class="usa-link">35130555</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>The publisher's version of this article is available at <a href="https://doi.org/10.1159/000521431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Stereotact Funct Neurosurg</a>
</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ABS1"><h2 data-anchor-id="ABS1"><a id="ABS1-anchor" data-anchor-id="ABS1" class="usa-anchor"></a>Abstract</h2>
<section id="S1"><h3 class="pmc_sec_title">Background:</h3>
<p id="P4">The Medtronic “Percept” is the first FDA approved deep
brain stimulation (DBS) device with sensing capabilities during active
stimulation. Its real-world signal recording properties have yet to be fully
described.</p></section><section id="S2"><h3 class="pmc_sec_title">Objective:</h3>
<p id="P5">This study details three sources of artifact (and potential
mitigations) in local field potential (LFP) signals collected by the
Percept, and assesses the potential impact of artifact on the future
development of adaptive DBS (aDBS) using this device.</p></section><section id="S3"><h3 class="pmc_sec_title">Methods:</h3>
<p id="P6">LFP signals were collected from seven subjects in both experimental
and clinical settings. The presence of artifacts and their effect on the
spectral content of neural signals were evaluated in both the stimulation ON
and OFF states using three distinct offline artifact removal techniques.</p></section><section id="S4"><h3 class="pmc_sec_title">Results:</h3>
<p id="P7">Template subtraction successfully removed multiple sources of
artifact, including 1) electrocardiogram (ECG), 2) non-physiologic
polyphasic artifacts, and 3) ramping related artifacts seen when changing
stimulation amplitudes. ECG removal from stimulation ON (at 0 mA) signals
resulted in spectral shapes similar to OFF stimulation spectra (averaged
difference in normalized power in theta, alpha, and beta bands ≤
3.5%). ECG removal using singular value decomposition was similarly
successful, though required subjective researcher input. QRS interpolation
produced similar recovery of beta-band signal, but resulted in residual
low-frequency artifact.</p></section><section id="S5"><h3 class="pmc_sec_title">Conclusions:</h3>
<p id="P8">Artifacts present when stimulation is enabled notably affected the
spectral properties of sensed signals using the Percept. Multiple discrete
artifacts could be successfully removed offline using an automated template
subtraction method. The presence of unrejected artifact likely influences
online power estimates, with the potential to affect aDBS algorithm
performance.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> deep brain stimulation, local field potentials, artifact removal, electrical stimulation, adaptive deep brain stimulation</p></section></section><section id="S6"><h2 class="pmc_sec_title" data-anchor-id="S6"><a id="S6-anchor" data-anchor-id="S6" class="usa-anchor"></a>Introduction</h2>
<p id="P9">Deep brain stimulation (DBS) is a treatment for patients with numerous
neurologic conditions, including Parkinson’s disease [<a href="#R1" class="usa-link" aria-describedby="R1" aria-expanded="false">1</a>–<a href="#R4" class="usa-link" aria-describedby="R4" aria-expanded="false">4</a>],
essential tremor [<a href="#R5" class="usa-link" aria-describedby="R5" aria-expanded="false">5</a>–<a href="#R7" class="usa-link" aria-describedby="R7" aria-expanded="false">7</a>], and dystonia [<a href="#R8" class="usa-link" aria-describedby="R8" aria-expanded="false">8</a>–<a href="#R11" class="usa-link" aria-describedby="R11" aria-expanded="false">11</a>], for whom
pharmacologic therapy is inadequate. Standard-of-care currently delivers DBS in a
continuous manner, without automated feedback to adjust therapy according to
changing motor signs. Recent work has focused on the development of adaptive DBS
(aDBS), where stimulation is modulated in response to a biomarker of the
patient’s clinical state [<a href="#R12" class="usa-link" aria-describedby="R12" aria-expanded="false">12</a>].
Neurophysiologic biomarkers, such as signal properties of subcortical local field
potentials (LFPs) recorded from the DBS lead itself, are frequently proposed as
feedback signals for aDBS systems [<a href="#R13" class="usa-link" aria-describedby="R13" aria-expanded="false">13</a>,<a href="#R14" class="usa-link" aria-describedby="R14" aria-expanded="false">14</a>]. For example, beta range (13–30 Hz)
oscillations recorded from the subthalamic nucleus (STN) have correlated with
symptoms of Parkinson’s disease [<a href="#R13" class="usa-link" aria-describedby="R13" aria-expanded="false">13</a>],
and beta-band power was successfully implemented as a control signal for
laboratory-based implementations of aDBS [<a href="#R15" class="usa-link" aria-describedby="R15" aria-expanded="false">15</a>–<a href="#R17" class="usa-link" aria-describedby="R17" aria-expanded="false">17</a>]. Similar paradigms
were trialed in cervical dystonia using lower frequency bands (4–12 Hz)
recorded from the globus pallidus (GP) [<a href="#R18" class="usa-link" aria-describedby="R18" aria-expanded="false">18</a>].
Successful application of aDBS using subcortical LFP biomarkers therefore relies on
accurate sensing of neural signals, particularly within frequency bands of
interest.</p>
<p id="P10">Initial studies investigating aDBS utilized externalized leads connected to
benchtop amplifiers, which allowed LFPs to be recorded during active stimulation
with a high signal-to-noise ratio [<a href="#R15" class="usa-link" aria-describedby="R15" aria-expanded="false">15</a>,<a href="#R19" class="usa-link" aria-describedby="R19" aria-expanded="false">19</a>]. Subsequent work has focused on
implementing such algorithms within fully implanted devices. Medtronic’s
first-generation investigational DBS internal pulse generator (IPG) with sensing
capabilities, the Activa PC+S, was successfully used in investigational aDBS systems
for Parkinson’s disease [<a href="#R17" class="usa-link" aria-describedby="R17" aria-expanded="false">17</a>] and
essential tremor [<a href="#R20" class="usa-link" aria-describedby="R20" aria-expanded="false">20</a>], though other studies
described difficulty sensing subcortical LFPs during active stimulation because of
artifacts [<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>–<a href="#R23" class="usa-link" aria-describedby="R23" aria-expanded="false">23</a>]. Sources of artifact included stimulation artifacts
[<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>,<a href="#R23" class="usa-link" aria-describedby="R23" aria-expanded="false">23</a>], electrocardiogram (ECG) [<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>,<a href="#R24" class="usa-link" aria-describedby="R24" aria-expanded="false">24</a>,<a href="#R25" class="usa-link" aria-describedby="R25" aria-expanded="false">25</a>], and clock noise [<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>]. Offline post-processing attempts to remove stimulation artifacts
were proposed, but were generally unable to fully remove it [<a href="#R26" class="usa-link" aria-describedby="R26" aria-expanded="false">26</a>]. Medtronic’s next generation investigational
device, the Summit RC+S, included design specification changes to address issues
with artifacts, including sense blanking, implementation of a fully differential
amplifier, active recharge, and improved connector seals [<a href="#R27" class="usa-link" aria-describedby="R27" aria-expanded="false">27</a>]. However, the RC+S remains limited to a small number
of centers and only in the research setting [<a href="#R28" class="usa-link" aria-describedby="R28" aria-expanded="false">28</a>].</p>
<p id="P11">Recently, the Medtronic Percept PC became the first FDA approved device with
the capability to sense LFPs during stimulation [<a href="#R29" class="usa-link" aria-describedby="R29" aria-expanded="false">29</a>]. Preliminary reports have highlighted the presence of ECG artifacts,
particularly when stimulation is turned ON [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>] (ON is a device status
setting, and can be configured to deliver no current if amplitude is set to 0 mA).
Other sources of artifacts included movement artifacts and those caused by turning
stimulation OFF or ON. Artifacts caused by ramping (changing stimulation amplitude),
as has been seen with the RC+S [<a href="#R27" class="usa-link" aria-describedby="R27" aria-expanded="false">27</a>], have not
been previously characterized. Two previous studies (pre-print) have noted the
presence of ON-stimulation artifacts [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>] and proposed methods for
artifact removal (focusing on ECG), though there has not been a direct comparison of
multiple methods. Nor has there been a comprehensive comparison of the LFP signal
properties recorded when stimulation is ON versus OFF after artifact removal. Given
the Percept offers multiple LFP sensing functionalities (<a href="#T1" class="usa-link">Table 1</a>), future experimental designs using the Percept
will rely on whether direct comparisons can be made between signals recorded by
different methods. The objective of this work was to therefore assess the
differences in signal properties recorded when stimulation was ON versus OFF,
including characterizing the presence of artifacts (such as ECG and those provoked
by changes in stimulation amplitude), assessing the effects of artifacts on spectral
content, and comparing multiple techniques for artifact removal.</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1:</h3>
<div class="caption p"><p id="P59">Percept LFP Recording Functionalities</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1">Sensing Method</th>
<th align="left" valign="top" rowspan="1" colspan="1">Recording Duration</th>
<th align="left" valign="top" rowspan="1" colspan="1">Environment</th>
<th align="left" valign="top" rowspan="1" colspan="1">Bipolar Channels Used</th>
<th align="left" valign="top" rowspan="1" colspan="1">Sensing During Stimulation?</th>
<th align="left" valign="top" rowspan="1" colspan="1">TimeDomain Data?</th>
<th align="left" valign="top" rowspan="1" colspan="1">On-Board Calculated Spectral Data?</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Signal Quality Check - Sense Channel
Test</td>
<td align="left" valign="top" rowspan="1" colspan="1">~20 s</td>
<td align="left" valign="top" rowspan="1" colspan="1">In clinic / lab</td>
<td align="left" valign="top" rowspan="1" colspan="1">Stimulation-compatible<a href="#TFN1" class="usa-link"><sup>*</sup></a>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Yes, full spectrum of the 20 s data
set</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Signal Quality Check - Calibration Test</td>
<td align="left" valign="top" rowspan="1" colspan="1">~20 s</td>
<td align="left" valign="top" rowspan="1" colspan="1">In clinic / lab</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Single (sandwiching stimulation
cathode)<a href="#TFN2" class="usa-link"><sup>**</sup></a>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes (0 mA stimulation only)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">LFP Montage</td>
<td align="left" valign="top" rowspan="1" colspan="1">~20 s</td>
<td align="left" valign="top" rowspan="1" colspan="1">In clinic / lab</td>
<td align="left" valign="top" rowspan="1" colspan="1">All<a href="#TFN3" class="usa-link"><sup>***</sup></a>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes, full spectrum of the 20 s data set</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Indefinite Streaming</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Continuous streaming</td>
<td align="left" valign="top" rowspan="1" colspan="1">In clinic / lab</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Stimulation-compatible<a href="#TFN1" class="usa-link"><sup>*</sup></a>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Brain Sense Streaming</td>
<td align="left" valign="top" rowspan="1" colspan="1">Continuous streaming</td>
<td align="left" valign="top" rowspan="1" colspan="1">In clinic / lab</td>
<td align="left" valign="top" rowspan="1" colspan="1">Single (sandwiching stimulation cathode)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Yes, predefined 5-Hz narrow band power,
updated every 10 min</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Brain Sense Events</td>
<td align="left" valign="top" rowspan="1" colspan="1">~30 s</td>
<td align="left" valign="top" rowspan="1" colspan="1">At home</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Single (sandwiching stimulation
cathode)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes, full spectrum of the 30 s data set</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Brain Sense Timeline</td>
<td align="left" valign="top" rowspan="1" colspan="1">Continuous streaming</td>
<td align="left" valign="top" rowspan="1" colspan="1">At home</td>
<td align="left" valign="top" rowspan="1" colspan="1">Single (sandwiching stimulation cathode)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="left" valign="top" rowspan="1" colspan="1">No</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Yes, predefined 5-Hz narrow band power,
updated every 10 min</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="TFN1">
<sup>*</sup><p class="display-inline" id="P60">Stimulation-compatible bipolar channels include only bipolar
configurations that “sandwich” the cathode in monopolar or
double monopolar stimulation settings using the middle contacts (i.e.
0–2, 0–3, 1–3, 8–10, 8–11, and 911).</p>
</div>
<div class="fn" id="TFN2">
<sup>**</sup><p class="display-inline" id="P61">Consecutively assesses configurations compatible with sensing during
single monopolar stimulation (i.e. 0–2, 13, 8–10, and
9–11).</p>
</div>
<div class="fn" id="TFN3">
<sup>***</sup><p class="display-inline" id="P62">Consecutively assesses all configurations compatible with
stimulation*, and then all configurations not compatible with stimulation
(i.e. bipolar recording pairs are adjacent contacts)</p>
</div>
</div></section></section><section id="S7"><h2 class="pmc_sec_title" data-anchor-id="S7"><a id="S7-anchor" data-anchor-id="S7" class="usa-anchor"></a>Methods</h2>
<section id="S8"><h3 class="pmc_sec_title">Subjects</h3>
<p id="P12">Seven subjects participated in this study (<a href="#T2" class="usa-link">Table 2</a>) after informed consent to protocols
approved by the local institutional review board. Each had a Percept IPG
connected to Medtronic 3389 leads, implanted in either the STN or GP. Subject
Sub05 also had a subdural cortical paddle (Medtronic Resume II 3587A25)
implanted over the left primary motor cortex (M1) from a previous
investigational protocol [<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>]. This
subject also had a Medtronic SC connected to a lead in the right STN. No other
subjects had additional IPGs other than the Percept device.</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2:</h4>
<div class="caption p"><p id="P63">Subject Demographics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" valign="top" rowspan="1" colspan="1"> Subject</th>
<th align="left" valign="top" rowspan="1" colspan="1">Age / Sex</th>
<th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th>
<th align="left" valign="top" rowspan="1" colspan="1">Recording Setting</th>
<th align="left" valign="top" rowspan="1" colspan="1">IPG Site</th>
<th align="left" valign="top" rowspan="1" colspan="1">Lead Target</th>
<th align="left" valign="middle" rowspan="1" colspan="1">Clinical Stimulation Settings (Contact /
Amplitude / Frequency / Pulse Width)</th>
<th align="left" valign="top" rowspan="1" colspan="1">Sensing Contacts</th>
<th align="left" valign="top" rowspan="1" colspan="1">Type of Artifact Identified by Percept</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sub01</td>
<td align="left" valign="middle" rowspan="1" colspan="1">46 / Male</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Holmes tremor</td>
<td align="left" valign="top" rowspan="1" colspan="1">Experimental</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Left chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left GP</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+2− / 2.7 mA / 130 Hz / 100
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 and 3</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="top" colspan="1">Sub02</td>
<td rowspan="2" align="left" valign="top" colspan="1">73 / Male</td>
<td rowspan="2" align="left" valign="middle" colspan="1">Parkinson’s disease
(Preoperative MDS- UPDRS: 79)</td>
<td rowspan="2" align="left" valign="top" colspan="1">Experimental</td>
<td rowspan="2" align="left" valign="top" colspan="1">Right chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left STN</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+1− / 2.6 mA / 125 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">0 and 2</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Right STN</td>
<td align="left" valign="top" rowspan="1" colspan="1">C+9− / 2.3 mA / 125 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">8 and 10</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sub03</td>
<td align="left" valign="top" rowspan="1" colspan="1">80 / Female</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Parkinson’s disease (Preoperative
MDS- UPDRS: 58)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Experimental + Clinical</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Right GP</td>
<td align="left" valign="top" rowspan="1" colspan="1">C+9− / 2.0 mA / 130 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">8 and 10</td>
<td align="left" valign="top" rowspan="1" colspan="1">SQC</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="top" colspan="1">Sub04</td>
<td rowspan="2" align="left" valign="top" colspan="1">66 / Female</td>
<td rowspan="2" align="left" valign="middle" colspan="1">Parkinson’s disease
(Preoperative MDS- UPDRS: 56)</td>
<td rowspan="2" align="left" valign="top" colspan="1">Experimental</td>
<td rowspan="2" align="left" valign="top" colspan="1">Left chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left GP</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+1− / 2.0 mA / 130 Hz / 70
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">0 and 2</td>
<td align="left" valign="top" rowspan="1" colspan="1">CT</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Right GP</td>
<td align="left" valign="top" rowspan="1" colspan="1">C+9− / 2.0 mA / 130 Hz / 70
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">8 and 10</td>
<td align="left" valign="top" rowspan="1" colspan="1">SQC</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="top" colspan="1">Sub05</td>
<td rowspan="2" align="left" valign="top" colspan="1">46 / Male</td>
<td rowspan="2" align="left" valign="middle" colspan="1">Parkinson’s disease
(Preoperative MDS- UPDRS: 34)</td>
<td rowspan="2" align="left" valign="top" colspan="1">Clinical</td>
<td rowspan="2" align="left" valign="top" colspan="1">Left chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left STN</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+1− / 1.6 mA / 130 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">0 and 2</td>
<td align="left" valign="top" rowspan="1" colspan="1">CT</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Left M1</td>
<td align="left" valign="top" rowspan="1" colspan="1">n/a</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 and 3</td>
<td align="left" valign="top" rowspan="1" colspan="1">SQC</td>
</tr>
<tr>
<td rowspan="2" align="left" valign="top" colspan="1">Sub06</td>
<td rowspan="2" align="left" valign="top" colspan="1">70 / Male</td>
<td rowspan="2" align="left" valign="top" colspan="1">Parkinson’s disease
(Preoperative</td>
<td rowspan="2" align="left" valign="top" colspan="1">Clinical</td>
<td rowspan="2" align="left" valign="top" colspan="1">Right chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left GP</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+1− / 5.9 mA / 140 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">0 and 2</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Right GP</td>
<td align="left" valign="middle" rowspan="1" colspan="1">C+9− / 5.4 mA / 140 Hz / 60
μs MDS- UPDRS: 79)</td>
<td align="left" valign="top" rowspan="1" colspan="1">8 and 10</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sub07</td>
<td align="left" valign="top" rowspan="1" colspan="1">72 / Male</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Parkinson’s disease (Preoperative
MDS- UPDRS: 71)</td>
<td align="left" valign="top" rowspan="1" colspan="1">Clinical</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left chest</td>
<td align="left" valign="top" rowspan="1" colspan="1">Left GP</td>
<td align="left" valign="top" rowspan="1" colspan="1">C+1− / 1.5 mA / 140 Hz / 60
μs</td>
<td align="left" valign="top" rowspan="1" colspan="1">0 and 2</td>
<td align="left" valign="top" rowspan="1" colspan="1">None</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="TFN4"><p id="P64">MDS-UPDRS, Movement Disorders Society Unified Parkinson’s
Disease Rating Scale (Part III collected in the offmedication state); SQC,
signal quality check (assessment when stimulation is off); CT, calibration
test (assessment when stimulation is on with amplitude at 0 mA,
(ON-0mA))</p></div></div></section></section><section id="S9"><h3 class="pmc_sec_title">Data Acquisition</h3>
<p id="P13">LFP signals were collected at 250 Hz from all subjects using the
“Brain Sense Streaming” mode (<a href="#T1" class="usa-link">Table 1</a>). DBS programming for each subject was configured to
monopolar stimulation at one of the two inner contacts (contacts 1/2 or 9/10),
and LFPs were sensed using the two contacts adjacent to the cathode in a bipolar
configuration (<a href="#T2" class="usa-link">Table 2</a>). Four subjects
(Sub01-Sub04) participated in the experimental paradigm defined below. An
additional distinct data set of LFPs were also collected from four subjects
(Sub03, and Sub05-Sub07) during routine clinical care and analyzed
retrospectively. Subject Sub03 participated both in the standardized experiment,
as well as supplied recordings from clinical care.</p>
<p id="P14">Subjects Sub01-Sub04 participated in a controlled experiment where time
series data were collected from subjects while at rest, with stimulation either
(1) OFF or (2) ON with amplitude equal to 0 mA (ON-0mA state). For the ON-0mA
state, all other stimulation parameters (such as stimulation frequency and pulse
width) were maintained as the patient’s clinical settings, as described
in <a href="#T2" class="usa-link">Table 2</a>. Two subjects had unilateral
implants and two subjects had bilateral implants, resulting in LFP recordings
from six individual hemispheres. Five repetitions of 15 s of signals were
collected for each subject in both stimulation states (only four repetitions of
ON-0mA for Sub02). The order of stimulation conditions was randomized.</p>
<p id="P15">For the signals collected during the course of clinical care for Sub03,
and Sub05-Sub07, time series data were collected simultaneously with the
stimulation amplitude (which was updated every 0.5 s). For Sub07, 20 s of
OFF-stimulation time-series data were also collected using the “LFP
Montage” (<a href="#T1" class="usa-link">Table 1</a>). The clinical
recordings included data collected when subjects were at rest and during exam
maneuvers (such as assessment of tone).</p></section><section id="S10"><h3 class="pmc_sec_title">Offline Artifact Removal</h3>
<p id="P16">All data was analyzed using MathWorks MATLAB r2021a. Time series data
were first low-pass filtered using forward-backward filtering with a
seventh-order Butterworth filter with a cutoff frequency of 100 Hz. Three
methods of ECG removal were assessed: a new template subtraction pipeline,
singular value decomposition (SVD), and QRS interpolation. The template
subtraction technique was also implemented to remove non-ECG repetitive
artifacts.</p>
<section id="S11"><h4 class="pmc_sec_title">Template Subtraction Pipeline</h4>
<p id="P17">Template subtraction [<a href="#R33" class="usa-link" aria-describedby="R33" aria-expanded="false">33</a>]
consisted of a four-step process (<a href="#F1" class="usa-link">Fig.
1</a>). The process is described below in detail for ECG removal,
along with modifications for use with other repetitive non-ECG
artifacts.</p>
<figure class="fig xbox font-sm" id="F1"><h5 class="obj_head">Fig. 1: Summary of template subtraction pipeline for ECG removal.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/8b24a2003dc1/nihms-1773152-f0001.jpg" loading="lazy" height="1800" width="904" alt="Fig. 1:"></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P52">Template subtraction consisted of a four-step process, including (1)
identification of a template seed (estimate of the artifact waveform), (2) use
of a modified Woody’s adaptive filter to identify locations of artifact
and recursively update the template shape, (3) a forced search for artifact
locations potentially missed by the Woody’s filter, and (4) subtraction
of the finalized template shape at identified timestamps.</p></figcaption></figure><ol id="L2" class="list" style="list-style-type:decimal">
<li><p id="P18">Template Seed Identification: For ECG removal, the template
seed identification was automated. Each possible 760 ms epoch within
the first 5 s of the signal was evaluated for possible ECG waveforms
(760 ms epoch was based on the upper limits of normal for PR and QT
intervals of 200 ms and 460 ms respectively, along with a 100 ms
buffer). Subsequently, each epoch was used as the “known
waveform” in a matched filter on the remaining signal, where
peaks of the matched filter output represented timestamps of
greatest correlation with the epoch’s waveform. The epoch
with the highest average peak filter output was identified (with a
constraint that the peaks be at least 0.5 s apart, equivalent to a
heart rate of 120 bpm). The template seed was then set as the
average of these waveform matches.</p></li>
<li><p id="P19">Modified Woody’s Adaptive Filter: Once a template
seed was identified, a modified Woody’s adaptive filter was
used to identify locations of artifact. As described in the original
paper by Woody [<a href="#R34" class="usa-link" aria-describedby="R34" aria-expanded="false">34</a>], this
approach cross-correlates an estimate of the artifact waveform with
the signal, identifies the maximum of the correlogram (a
“match” for where the artifact is present), and then
uses the signal epoch of this match to iteratively update the
artifact template waveform estimate by averaging all current matches
together. This process repeats until the estimate of the artifact
waveform converges and all instances of the artifact are identified.
For efficiency, the modified Woody’s filter for this study
was implemented using a matched filter to identify the timestamps of
correlation local maxima, with the constraint that the timestamps be
at least 0.5 s apart (equivalent to a heart rate of 120 bpm). To
minimize the false positive rate, the matched filter output was also
required to exceed a threshold (97.5th percentile of filter output
for the entire signal) to be included.</p></li>
<li><p id="P20">Forced Search for Missed Artifacts Identification: Use of a
threshold with the Woody’s filter resulted in decreased
sensitivity (but higher specificity) of artifact detection.
Potential timestamps of missed artifact detection were identified by
finding epochs where the inter-timestamp duration exceeded 1.5 times
the mode of the inter-timestamp durations. Within each identified
epoch, the number of missed artifacts was estimated (N). A matched
filter was used to find N timestamps with the greatest correlation
to the Woody’s filter’s output template.</p></li>
<li><p id="P21">Subtraction of Artifact Template: Once all artifact
timestamps were identified, a cleaned signal was produced by
subtracting the Woody’s filter output template from the
signal at the determined timestamps. If the duration between
timestamps was smaller than the length of the template, the template
was trimmed to prevent overlap and redundancy of template
subtraction.</p></li>
</ol>
<p id="P22">For signals where the automated template seed identification did not
produce ECG artifacts, the subtracted ECG template was produced by averaging
epochs of the hemisphere of interest at the artifact timestamps identified
in the contralateral hemisphere. If neither hemisphere produced an automated
ECG template seed, and no ECG could be observed by visually inspecting the
signals, the signals were considered to be absent of ECG. For experimental
conditions with multiple trials (e.g., experiments comparing the signal
properties when stimulation is OFF versus ON-0mA), the template seeds and
the final templates subtracted from the signals were averaged across all
trials within the same subject and experimental condition.</p>
<p id="P23">For implementation of template subtraction with non-ECG artifacts,
the template seed was manually selected as an epoch of signal including
artifacts. The required minimum time between peaks of matched filter output
was ninety percent of a manual estimate of the typical duration between
artifact incidences.</p></section><section id="S12"><h4 class="pmc_sec_title">Singular Value Decomposition (SVD)</h4>
<p id="P24">SVD was implemented as previously described for ECG removal [<a href="#R25" class="usa-link" aria-describedby="R25" aria-expanded="false">25</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>]. In brief -- epochs of M samples (corresponding to 760 ms,
or trimmed as above if epochs overlapped) were extracted at timestamps of
ECG incidence (identified by the same technique used with template
subtraction). For experimental conditions with multiple trials, ECG epochs
were grouped within each combination of subject and experimental condition,
producing a MxP matrix (where P is the number of ECG artifacts). SVD of this
matrix produced a set of projections equivalent to projections onto
principal component eigenvectors. Eigenvector projections that extracted
signals consistent with ECG morphology were identified by visual inspection
and selected as artifact-related. Artifact-related projections were then
used to reconstruct ECG estimates at each timestamp, which were subsequently
subtracted.</p></section><section id="S13"><h4 class="pmc_sec_title">QRS Interpolation</h4>
<p id="P25">QRS interpolation was a modified version of an online repository
script for processing signals collected from the Percept [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>]. This method identifies the location of QRS
complexes (the polyphasic component of the ECG reflecting cardiac
ventricular depolarization [<a href="#R35" class="usa-link" aria-describedby="R35" aria-expanded="false">35</a>]), and
the artifact is removed by interpolation, where the QRS complex is replaced
by the signal immediately preceding and immediately following the identified
QRS. This method was implemented as published in the repository, except QRS
complexes were instead identified using 100 ms epochs within ECG artifacts
identified by the template subtraction method for consistency.</p></section></section><section id="S14"><h3 class="pmc_sec_title">Offline Spectral Analysis and Power Normalization</h3>
<p id="P26">For subjects Sub01-Sub05, the power spectra of signals collected in the
OFF and ON-0mA state were calculated, both before and after artifact removal.
For subjects with bilateral DBS implants, each hemisphere was assessed. The
power spectra of LFP data were calculated using the Welch method, with a 1 s
window and 50% overlap. For Sub01-Sub04, the integrated power within three
spectral bands (theta: 4–7.5 Hz, alpha 8–13 Hz, and beta
13.5–30 Hz) was calculated for each trial. The average percent difference
of power between cleaned ON-0mA and OFF-stimulation signals were calculated for
each power band and ECG removal technique, and then averaged across subjects. To
account for possible broad spectral scaling differences between OFF and ON-0mA
sensing conditions (which affect absolute power estimates but not shape of the
power spectrum), spectral power was normalized by integrated gamma power
(30–100 Hz), given the minimal gamma content of ECG artifacts.</p>
<p id="P27">To assess how artifacts might impact embedded estimates of spectral
power (“Brain Sense” mode), we calculated estimates of narrow band
(5 Hz-wide) power centered on two frequencies in the alpha and beta ranges.
Power estimates were updated every 3 s, where the Welch method was implemented
on the preceding 3 s epoch, using a 1 s window and 50% overlap.</p></section></section><section id="S15"><h2 class="pmc_sec_title" data-anchor-id="S15"><a id="S15-anchor" data-anchor-id="S15" class="usa-anchor"></a>Results</h2>
<section id="S16"><h3 class="pmc_sec_title">ECG Artifact</h3>
<p id="P28">LFP signals recorded by the Percept in Sub01-Sub04 demonstrated notably
different power spectra when collected with stimulation OFF versus ON-0mA (<a href="#F2" class="usa-link">Fig. 2</a>), and were primarily caused by the
presence of ECG artifacts (<a href="#F3" class="usa-link">Fig. 3A</a>). For
two hemispheres (Sub02-R and Sub 04-R), ECG artifacts were not visually apparent
in ON-0mA signals, and were only extracted by averaging epochs at timestamps
identified from the contralateral hemisphere. No ECG artifact could be
identified by visual inspection or by automated template seed generation for any
subject when recorded in the OFF-stimulation state.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Fig. 2: LFP spectral content when stimulation is OFF versus ON-0mA.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/54ea7d94d536/nihms-1773152-f0002.jpg" loading="lazy" height="1800" width="1812" alt="Fig. 2:"></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P53">Turning on stimulation (though not delivering any current) resulted in
significant change in the LFP power spectrum. Removal of ECG artifact from
ON-0mA signals using template subtraction resulted a scaled spectral shape more
similar to signals collected when stimulation was OFF. However, there was not a
consistent scaling factor between subjects/hemispheres. Note, the power spectra
shown are not normalized. Shaded region represents standard error. L, left
hemisphere. R, right hemisphere. PSD, power spectral density.</p></figcaption></figure><figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Fig. 3: ECG artifact removal from LFP signals.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/4d0715a57726/nihms-1773152-f0003.jpg" loading="lazy" height="1854" width="1920" alt="Fig. 3:"></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P54">(A) Sample LFP data from Sub01-Sub04 and the corresponding ECG artifact
template that was extracted by the template subtraction method (seen at
approximately time = 5.5–6.25 s). Comparison of ECG removal techniques
and their effect on the (B) time-series data and (C) power spectrum, for a
sample signal from Sub03-L. QRS interpolation left behind T-waves, which
resulted in retained low-frequency content from the artifact. Both template
subtraction and SVD removed this low-frequency artifact component. PSD, power
spectral density.</p></figcaption></figure><p id="P29">ECG artifact morphology varied between subjects (<a href="#F3" class="usa-link">Fig. 3A</a>). A QRS complex was present in all cases,
though the prominence of P waves (ECG components reflecting cardiac atrial
depolarization [<a href="#R35" class="usa-link" aria-describedby="R35" aria-expanded="false">35</a>]) and T waves (ECG
components reflecting cardiac ventricular repolarization [<a href="#R35" class="usa-link" aria-describedby="R35" aria-expanded="false">35</a>]) varied. QRS interpolation resulted in adequate
removal of QRS complexes, but resulted in retained low-frequency artifacts in
subjects with significant P or T waves (<a href="#F3" class="usa-link">Fig.
3B</a>–<a href="#F3" class="usa-link">C</a>). In contrast, both
template subtraction and SVD methods similarly removed the full ECG artifact,
including both low- and high-frequency components. For each subject/hemisphere,
only the first eigenvector projection calculated by SVD produced projections
that extracted clear ECG artifacts on visual inspection (the requirement for
eigenvector inclusion in SVD artifact removal per previously reported
implementations [<a href="#R25" class="usa-link" aria-describedby="R25" aria-expanded="false">25</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>]). For four of the six hemispheres, the mean SVD
projections produced a morphology very similar to the template identified by
template subtraction (<a href="#F4" class="usa-link">Fig. 4</a>). Hemispheres
that demonstrated the greatest difference between the two methods (Sub02-R and
Sub04-R) were those where the first eigenvector accounted for the smallest
variance explained (<a href="#T3" class="usa-link">Table 3</a>) and where
the ECG artifacts were smallest in amplitude compared to the underlying LFP
signal (<a href="#F3" class="usa-link">Fig. 3A</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Fig. 4: Comparison of the ECG templates used for template subtraction and averaged
SVD projections for each subject.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/a9189d587571/nihms-1773152-f0004.jpg" loading="lazy" height="1364" width="1909" alt="Fig. 4:"></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P55"><strong>SVD</strong> projections include only the first principal component
eigenvector. The morphology of the averaged SVD projections were similar to the
template used for template subtraction. The two estimates were more likely to
differ when the first eigenvector accounted for a smaller variance explained
(<a href="#T3" class="usa-link">Table 3</a>).</p></figcaption></figure><section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3:</h4>
<div class="caption p"><p id="P65">Variance explained by visually identified<a href="#TFN5" class="usa-link"><sup>*</sup></a> SVD projections with appearance of ECG</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" valign="middle" rowspan="1" colspan="1">Subject</th>
<th align="left" valign="middle" rowspan="1" colspan="1">Variance Explained</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub01 – Left</td>
<td align="left" valign="middle" rowspan="1" colspan="1">70.8%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub02 – Left</td>
<td align="left" valign="middle" rowspan="1" colspan="1">38.4%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub02 – Right</td>
<td align="left" valign="middle" rowspan="1" colspan="1">13.9%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub03 – Right</td>
<td align="left" valign="middle" rowspan="1" colspan="1">75.0%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub04 – Left</td>
<td align="left" valign="middle" rowspan="1" colspan="1">41.2%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Sub04 – Right</td>
<td align="left" valign="middle" rowspan="1" colspan="1">16.4%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="TFN5">
<sup>*</sup><p class="display-inline" id="P66">For each subject, only the first eigenvector projection was visually
identified as contributing to ECG waveform morphology</p>
</div></div></section><p id="P30">Removal of ECG artifacts from ON-0mA signals by template subtraction
resulted in power spectral shapes (i.e., the relative relationship between
spectral content at different frequencies) more similar to those seen when
stimulation was OFF (<a href="#F2" class="usa-link">Fig. 2</a>). In
particular, hemispheres with prominent T waves (Sub01-L, Sub 03-R, Sub04-L, and
Sub04-R) demonstrated a reduction in delta-range spectral peak prominence
(approximately 2–3 Hz). Hemispheres with large QRS amplitudes compared to
underlying LFP amplitude (Sub02-L, Sub03-R) showed reduction in alpha-beta range
prominence. For subjects where the ECG artifact amplitude was smaller compared
to the underlying LFP signal (<a href="#F3" class="usa-link">Fig. 3</a>,
Sub02-R and Sub04-R), the effect of ECG removal on spectral shape was less
pronounced. SVD produced similar recovery of ON-0mA spectral shape when compared
to template subtraction for all subjects and is not shown. For some subjects,
although the shape was retained, the spectral magnitude was not equivalent
between the two conditions, and this scaling factor was not consistent across
subjects or across the two hemispheres within a subject. The presence of scaling
factor differences between OFF and ON-0mA spectra required the use of spectral
normalization for comparison between conditions. Averaged difference in
normalized power in theta, alpha, and beta bands were less than 3.5% for both
template subtraction and SVD (<a href="#T4" class="usa-link">Table 4</a>).
QRS interpolation resulted in ON-0mA spectra that were less similar to OFF
spectra. The difference between QRS interpolation and the other two methods was
greatest for the theta band, which also showed the greatest variability in
accuracy (92.0 ± 48.3% difference between ON-0mA and OFF for QRS
interpolation). For subjects where the ECG artifact amplitude was smaller
compared to the underlying LFP signal (<a href="#F3" class="usa-link">Fig.
3</a>, Sub02-R and Sub04-R), the effect of ECG removal on normalized
power was also less pronounced.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">Table 4:</h4>
<div class="caption p"><p id="P67">Effect of ECG removal by three different methods on the normalized
spectral power in physiologically relevant frequency bands</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" valign="top" rowspan="1" colspan="1"></th>
<th colspan="4" align="left" valign="top" rowspan="1">Percentage difference of
normalized power between signals recorded with stimulation ON-0mA (after
artifact removal) versus stimulation OFF</th>
</tr>
<tr>
<th align="left" valign="top" rowspan="1" colspan="1">Spectral Band</th>
<th align="left" valign="top" rowspan="1" colspan="1">No Artifact Removal</th>
<th align="left" valign="top" rowspan="1" colspan="1">Template Subtraction</th>
<th align="left" valign="top" rowspan="1" colspan="1">SVD</th>
<th align="left" valign="top" rowspan="1" colspan="1">QRS Interpolation</th>
</tr>
</thead>
<tbody>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Averaged Across Subjects /
Hemispheres ± Standard Error</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">105.3 ± 52.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.0 ± 7.8%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−3.2 ± 7.3%</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.0 ± 48.3%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">115.4 ± 69.3%</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0 ± 10.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7 ± 10.4%</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.7 ± 15.9%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.8 ± 46.8%</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.3 ± 9.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.7 ± 9.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−3.6 ± 13.2%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub01-L</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">234.7%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−0.7%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−6.8%</td>
<td align="center" valign="top" rowspan="1" colspan="1">317.7%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">75.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−8.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−9.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.6%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.8%</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.6%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub02-L</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">42.7%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">120.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">68.3%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">162.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">32.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">43.2%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub02-R</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−8.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−5.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.2%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−31.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−34.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−38.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−39.8%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−25.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−34.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−36.4%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−38.1%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub03-R</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">301.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−15.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−19.3%</td>
<td align="center" valign="top" rowspan="1" colspan="1">129.1%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">446.7%</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">41.1%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">272.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">22.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.8%</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.0%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub04-L</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−18.4%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−19.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">18.1%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.4%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−12.3%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−14.1%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−15.8%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−13.5%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−15.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−24.0%</td>
</tr>
<tr><td colspan="5" align="center" valign="top" rowspan="1">
<strong>Sub04-R</strong>
</td></tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Theta (4–7.5 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">34.6%</td>
<td align="center" valign="top" rowspan="1" colspan="1">29.2%</td>
<td align="center" valign="top" rowspan="1" colspan="1">26.3%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Alpha (8–13 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.0%</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.7%</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.5%</td>
</tr>
<tr>
<td align="justify" valign="top" rowspan="1" colspan="1">Beta (13.5–30 Hz)</td>
<td align="center" valign="top" rowspan="1" colspan="1">−1.7%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−3.9%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−5.3%</td>
<td align="center" valign="top" rowspan="1" colspan="1">−28.2%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="S17"><h3 class="pmc_sec_title">Non-ECG Artifact</h3>
<p id="P31">Signals recorded within clinical care for Sub05 (STN and motor cortex
electrodes) demonstrated repetitive polyphasic artifacts in the ON-0mA state
(<a href="#F5" class="usa-link">Fig. 5A</a>). Template subtraction
successfully eliminated both lower and higher frequency components of these
artifacts, as visualized in the time domain (<a href="#F5" class="usa-link">Fig.
5B</a> and <a href="#F5" class="usa-link">5D</a>). For the M1
recordings, spectra collected during ON-0mA demonstrated lower spectral
magnitudes compared to OFF stimulation spectra, even at frequencies where
artifact rejection via template subtraction did not produce significant changes
to the ON-0mA spectra (frequencies &gt; 15 Hz, <a href="#F5" class="usa-link">Fig. 5E</a>).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5: Efficacy of template subtraction on non-ECG artifact.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/0e023aa03d83/nihms-1773152-f0005.jpg" loading="lazy" height="1800" width="1420" alt="Figure 5:"></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P56">(A) Signals collected from Sub05 as part of their standard clinical care
demonstrated a repetitive, stereotyped artifact when stimulation was turned on,
irrespective of stimulation amplitude. This persisted when stimulation amplitude
was decreased to zero (ON-0mA). * Timepoints of data used for analysis of OFF
stimulation signals in B-E. ** Timepoints of data used for analysis of ON-0mA
signals in B-E. The template subtraction removed the artifact from both (B) STN
and (D) M1 signals, resulting in a decrease of the low-frequency spectral
content (C and E). PSD, power spectral density.</p></figcaption></figure><p id="P32">Additional sources of artifact included transient artifacts that were
introduced with changes in stimulation parameters (Δ-stimulation
artifacts, <a href="#F6" class="usa-link">Fig. 6</a>). The direction of these
artifacts changed depending on whether stimulation was increased or decreased,
and the magnitude of the artifact increased with increasing rates of amplitude
change. A transient very high-amplitude artifact was also produced in some
subjects by simply enabling stimulation (turning stimulation from OFF to
ON-0mA).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Fig. 6: Artifact produced by changing stimulation amplitude.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/a9fd7702b1ed/nihms-1773152-f0006.jpg" loading="lazy" height="2017" width="1922" alt="Fig. 6:"></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P57">(A) LFP signals collected from Sub06 during stimulation ramping with
concurrent Δ-stimulation artifact. (B) Signals collected from Sub07
demonstrated Δ-stimulation artifact with ramping (black arrows). A larger
artifact was produced by a quicker ramp rate. (C) Additional signals collected
from Sub07 again demonstrated Δ-stimulation artifact with ramping
(arrows), as well as an artifact produced by switching from the OFF to the
ON-0mA stimulation state (red arrow).</p></figcaption></figure><p id="P33">Signals recorded during the clinical care of Sub03 demonstrated both ECG
artifacts and Δ-stimulation artifacts during stimulation ramping (<a href="#F7" class="usa-link">Fig. 7</a>). The stimulation amplitude was ramped
with a constant current increment, producing Δ-stimulation artifacts with
a constant magnitude and morphology. Both the Δ-stimulation and ECG
artifacts were successfully removed using the template subtraction method
offline. A 5 Hz frequency band centered at both 8.78 Hz (alpha range) and 16.60
Hz (beta range) of the unprocessed LFP signal showed increased power during
stimulation ramping, which resolved when the Δ-stimulation artifacts were
removed from the signal using the template subtraction pipeline.</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Fig. 7: Effect of Δ-stimulation artifact on narrow-band spectral
analysis.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36bd/9064887/dd11f4312786/nihms-1773152-f0007.jpg" loading="lazy" height="1800" width="1225" alt="Fig. 7:"></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p id="P58">(A) LFP signals collected from Sub03 during stimulation ramping (shaded
grey epochs) with concurrent Δ-stimulation artifact. Signals enclosed in
the dashed rectangle are enlarged in (B), demonstrating removal of ECG and the
Δ-stimulation artifact using template subtraction. (C) Power spectral
density (PSD) of OFF-stimulation LFP signals demonstrated a peak at 8.57 Hz
(black arrow) and 16.60 Hz (red arrow). (D) Integrated power (calculated
offline) within a 5 Hz band centered on 8.57 Hz, with and without artifact
removal. (E) Integrated power within a 5 Hz band centered on 16.60 Hz, with and
without artifact removal. Note for (D,E) that for regions of the plot without
grey shading (i.e., no ramping), signals with the ECG removed (blue) and ECG +
Δ-stimulation removed (red) are expected to overlap.</p></figcaption></figure></section></section><section id="S18"><h2 class="pmc_sec_title" data-anchor-id="S18"><a id="S18-anchor" data-anchor-id="S18" class="usa-anchor"></a>Discussion</h2>
<p id="P34">This study provides an evaluation of LFP signal characteristics (including
sources of artifacts and potential mitigation strategies) recorded by the Medtronic
Percept PC, the first commercially available sensing-enabled DBS system. We
demonstrate that sensing LFP signals when stimulation is OFF is not equivalent to
sensing when stimulation is ON, which has important implications for both clinical
and research applications. Similar to other reports [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>], simply enabling
stimulation (even without delivered current, i.e., the ON-0mA state) introduced
artifacts not observed when stimulation was OFF. Sources of artifact extended beyond
the electrical stimulation pulse artifact, and in contrast to previous experiences
with the PC+S [<a href="#R21" class="usa-link" aria-describedby="R21" aria-expanded="false">21</a>,<a href="#R23" class="usa-link" aria-describedby="R23" aria-expanded="false">23</a>], the Percept did not produce subharmonic waveforms in
frequency bands &lt; 100 Hz. Artifacts observed in this study included ECG
(<a href="#F3" class="usa-link">Fig. 3</a>), a polyphasic waveform in a
patient with a concurrent subdural paddle (<a href="#F5" class="usa-link">Fig.
5</a>), and an artifact produced during changes in stimulation amplitude
(Δ-stimulation artifact, <a href="#F6" class="usa-link">Fig. 6</a>). These
artifacts each had a stereotyped morphology, allowing them to be removed during
offline post-processing with an automated template subtraction algorithm (<a href="#F2" class="usa-link">Figs. 2</a>–<a href="#F3" class="usa-link">3</a> and <a href="#F5" class="usa-link">5</a>–<a href="#F6" class="usa-link">6</a>). In addition to introducing artifacts, enabling
stimulation resulted in a multiplicative scaling difference for some patients (<a href="#F2" class="usa-link">Fig. 2</a>), therefore requiring normalization for
within-subject comparison between OFF- versus ON-recorded signals. The presence of
both artifacts and scaling differences influenced spectral power estimates (<a href="#F2" class="usa-link">Figs. 2</a> and <a href="#F7" class="usa-link">7</a>), and therefore has the potential to affect the accuracy of LFP data
used in clinical care, research, and aDBS algorithms. We recommend recording in the
ON-0mA state when collecting baseline recordings aimed at biomarker detection in the
absence of stimulation, both for clinical- and research-based applications. However,
recording in this mode permits only a limited montage (single bipolar channel that
are “stimulation-compatible”, see <a href="#T1" class="usa-link">Table 1</a>). If additional sensing channels are desired, these can be
collected OFF stimulation and processed using the pipeline enclosed herein prior to
comparison with ON-stimulation signals.</p>
<p id="P35">ECG artifacts have been similarly reported by other groups [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>,<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>], more
commonly when the IPG was implanted in the left chest wall [<a href="#R31" class="usa-link" aria-describedby="R31" aria-expanded="false">31</a>]. Susceptibility to ECG, as with the PC+S, is likely
due to possible insufficiency of connector seals and the use of passive recharge
after stimulation, which increases the duration the electrodes are connected to the
case for redistribution of charge at the tissue-electrode interface after the
stimulation impulse is delivered [<a href="#R27" class="usa-link" aria-describedby="R27" aria-expanded="false">27</a>]. In
this study, directed analysis revealed that ECG was present in all LFP signals
assessed and contributed to artifactual distortion of the PSD in lower frequency
bands, even when there was no clear artifact on visual inspection of the raw time
series (<a href="#F2" class="usa-link">Figs. 2</a>–<a href="#F3" class="usa-link">3</a>). Effective artifact removal techniques are therefore
important to implement prior to further analysis.</p>
<p id="P36">Of the ECG removal methods evaluated, we chose template subtraction for
rejection of both ECG and other artifacts prior to spectral analysis, given evidence
of accurate artifact removal, its automated nature, and the ability to extend this
method to any repetitive artifact with stereotyped morphology. Removal of ECG using
template subtraction and SVD both resulted in the improvement of the original
spectral pattern compared to signals recorded at baseline with stimulation OFF (with
low frequency power differences of &lt; 3.5%), suggesting near full removal of
ECG from the signals (<a href="#F2" class="usa-link">Fig. 2</a> and <a href="#T4" class="usa-link">Table 4</a>). Template subtraction assumed stationarity of
the ECG artifacts, which was adequate for the short-duration signals assessed in
this study. A limitation of the SVD method was its visual identification of
eigenvector projections. Eigenvectors were likely missed by this approach, as there
may have been projections that contributed to components of the artifacts, but did
not resemble the full ECG artifacts themselves. This limitation may explain why
SVD-derived ECG artifacts differed from those extracted by template subtraction when
the first principal component explained less variance (<a href="#F4" class="usa-link">Fig. 4</a> and <a href="#T3" class="usa-link">Table 3</a>). In contrast,
QRS interpolation produced less accurate recovery of power in lower frequencies,
corresponding to the spectral content of P and T waves (<a href="#T4" class="usa-link">Table 4</a>). QRS interpolation does have the potential for
quick implementation, and would be adequate for circumstances where either lower
frequency bands are not of interest or where signal artifacts contain minimal P or T
waves. Though a similar approach could be extended for other short-duration
artifacts, the interpolation method cannot be easily extended to remove
longer-duration artifacts (such as full ECG morphologies), as this would require
interpolation of large percentages of the signal.</p>
<p id="P37">Non-ECG, polyphasic, repetitive artifacts were also seen in one subject
(Sub05; STN and cortical lead) when the device was in the ON state (<a href="#F5" class="usa-link">Fig. 5</a>). The artifacts were present in multiple
recordings, collected in different environments. It is unclear to what degree the
connection of a subdural paddle electrode to the Percept or the presence of a
contralateral Medtronic Activa SC contributed to the artifacts. Template subtraction
also successfully removed these artifacts (visualized in the time domain), providing
proof of principle for removal of idiosyncratic, stereotyped artifacts. Recovery of
the power spectral pattern when comparing ON-0mA versus OFF was less complete here
than with the controlled experiment with Sub01-Sub04. Given the spectral difference
was also noted at frequencies where artifact removal had little effect (&gt; 15
Hz), this difference was likely not due to the artifact removal method. Instead,
this difference may have been due to the nature of the clinical recording, which
lacked repetitions and randomization, did not require the subject to be at rest
throughout the recordings, and did not have a washout period to account for delayed
resolution of stimulation effects [<a href="#R36" class="usa-link" aria-describedby="R36" aria-expanded="false">36</a>]. The
analyzed ON-0mA epoch was chosen to provide the greatest possible delay after
stimulation amplitude ceased, but this may have been insufficient. Another potential
cause for differences between ON-0mA and OFF stimulation spectra includes the lack
of normalization by gamma power, which was not performed because the signals were
collected under clinical conditions with possible differences in subject activity
level at different times of the recording.</p>
<p id="P38">Additional artifacts (Δ-stimulation artifacts) occurred in many
subjects when stimulation was being turned ON/OFF (similar to [<a href="#R32" class="usa-link" aria-describedby="R32" aria-expanded="false">32</a>]) or the amplitude was changed (<a href="#F6" class="usa-link">Fig. 6</a>). Artifacts did not precisely sync with recorded
stimulation changes because of differences in temporal resolution between neural
time series data (reported at 250 Hz), the Percept’s record of the concurrent
stimulation amplitude (updated every 500 ms), and timestamps of stimulation ON/OFF
changes (resolution of 1 s). However, the artifact orientation reversed with
different directions of stimulation ramping and was larger for greater rates of
stimulation change, suggesting it directly resulted from the change in stimulation.
Such artifacts have not been previously reported with the Percept, but have been
seen with the RC+S, and were attributed to discharge of residual voltage on the
electrode coupling capacitor [<a href="#R27" class="usa-link" aria-describedby="R27" aria-expanded="false">27</a>].
Stimulation amplitude ramping that occurred at constant current increments produced
Δ-stimulation artifacts with consistent morphology and amplitude, allowing it
to also be removed using offline template subtraction (<a href="#F7" class="usa-link">Fig. 7</a>).</p>
<p id="P39">The presence of a possible multiplicative scaling between OFF and ON-0mA
spectra after artifact removal in some patients (<a href="#F2" class="usa-link">Fig.
2</a>) suggests the additional need to normalize Percept-acquired LFP data
prior to further analysis. The cause of this multiplicative scaling, which was not
consistent across subjects, is unclear. It is possible that this scaling difference
was introduced by the ECG removal itself, however this is unlikely as this would
suggest that artifact subtraction results in either (1) the excessive removal of or
(2) the addition of frequency content that exactly mirrors the underlying
neurophysiologic signals. Reviews of the Percept’s internal hardware and
sensing methods do not describe the use of different gains for ON versus OFF
stimulation recordings [<a href="#R29" class="usa-link" aria-describedby="R29" aria-expanded="false">29</a>,<a href="#R30" class="usa-link" aria-describedby="R30" aria-expanded="false">30</a>] (confirmed directly with Medtronic). Future work
should expand this evaluation to a larger subject pool to evaluate how commonly this
effect is seen.</p>
<p id="P40">The artifact removal methods assessed were designed to be performed offline
during research use, and would not be implementable in the real-time clinical
setting. Onboard machine learning algorithms on the Percept flag channels with
potential artifacts, but their accuracy was variable. In our study, all subjects
demonstrated artifacts in some form, yet not all were flagged (<a href="#T2" class="usa-link">Table 2</a>). The clinician can override the default
settings and choose to visualize the spectra of flagged channels. However, this
should be done with caution as common artifacts (e.g., ECG) contain spectral content
that overlap with frequency bands of clinical interest [<a href="#R13" class="usa-link" aria-describedby="R13" aria-expanded="false">13</a>,<a href="#R18" class="usa-link" aria-describedby="R18" aria-expanded="false">18</a>], and could
confound clinical assessments of how stimulation is affecting the power spectrum.
Unfortunately, the Percept system does not allow the clinician to inspect the time
series signals for artifacts.</p>
<p id="P41">A Percept-based aDBS clinical trial is underway using narrow-band beta power
as a control signal [<a href="#R29" class="usa-link" aria-describedby="R29" aria-expanded="false">29</a>]. Our study
demonstrated that Δ-stimulation artifacts transiently affected spectral
content after the stimulation change (<a href="#F7" class="usa-link">Fig. 7</a>),
which is relevant for potential aDBS implementation. The Δ-stimulation
artifacts produced a greater increase in spectral power at lower frequencies
(theta/alpha range, corresponding to dystonia biomarkers [<a href="#R18" class="usa-link" aria-describedby="R18" aria-expanded="false">18</a>] or harmonics of Parkinsonian tremor frequency [<a href="#R37" class="usa-link" aria-describedby="R37" aria-expanded="false">37</a>]), though also affected narrow-band beta
power (Parkinsonism [<a href="#R13" class="usa-link" aria-describedby="R13" aria-expanded="false">13</a>]) as well. This
artifact has the most potential to complicate single-threshold aDBS algorithms
[<a href="#R15" class="usa-link" aria-describedby="R15" aria-expanded="false">15</a>], where aDBS stimulation is adjusted
on a shorter time-scale and may inappropriately react to artifactual increases in
narrow-band power after stimulation changes. Longer timescale (i.e., dual-threshold)
aDBS could also be impacted, as the frequency content of the QRS complex has the
potential to confound the beta-band biomarker (particularly as cardiac rate is
strongly mediated by activity levels).</p>
<p id="P42">Limitations of this study include that the formalized assessment of artifact
removal with OFF versus ON-0mA spectra across multiple subjects was only performed
for the ECG artifact. The polyphasic artifacts seen in the patient with concurrent
subdural electrodes over M1 (<a href="#F5" class="usa-link">Fig. 5</a>) was not
observed in any other patient in our center, preventing repetition in other
subjects. The Δ-stimulation artifacts were only produced during changes in
stimulation amplitude, and therefore could not be assessed in an environment without
delivered current (which would confound analysis given stimulation effect on the
underlying neurophysiologic signals). The evaluation of signals recorded in the
context of clinical care were also limited by their lack of constrained experimental
conditions, introducing potential confounders (such as in the comparisons between
OFF and ON-0mA in <a href="#F5" class="usa-link">Fig. 5</a>). Limitations stemming
for the Percept device itself include its fixed sampling rate of 250 Hz, which
introduces the potential of aliased stimulation artifact into frequency bands of
interest. Offline lowpass filtering was used to address this, and there was no
apparent subharmonic aliasing in frequencies less than 100 Hz. Finally, this study
does not assess the influence of artifacts on the real-time implementation of aDBS
(only offline), which was limited by the inability for Percept-based aDBS
configuration outside the confines of the manufacturer’s clinical trial.
Additionally, further studies will need to assess how the release of new DBS leads
and lead extension hardware [<a href="#R38" class="usa-link" aria-describedby="R38" aria-expanded="false">38</a>] affects
sources of noise and potential mitigation strategies.</p></section><section id="S19"><h2 class="pmc_sec_title" data-anchor-id="S19"><a id="S19-anchor" data-anchor-id="S19" class="usa-anchor"></a>Conclusion</h2>
<p id="P43">We demonstrate that the Medtronic Percept PC’s sensing of LFP signals
when stimulation is enabled is not equivalent to sensing when stimulation is OFF,
because of the introduction of multiple artifacts and scaling factors. Use of (1) an
automated template subtraction pipeline to remove artifacts with stereotyped
waveforms and (2) spectral normalization may allow for direct comparisons between
these two conditions in an offline analysis. If not adequately removed, the presence
of artifact influences estimation of spectral biomarkers.</p></section><section id="S20" class="ack"><h2 class="pmc_sec_title" data-anchor-id="S20"><a id="S20-anchor" data-anchor-id="S20" class="usa-anchor"></a>Acknowledgements</h2>
<p id="P44">We would like to acknowledge Dr. Juan Ansó for reviewing the
manuscript. We also acknowledge helpful discussions with members of the OpenMind
Consortium, supported by NIH BRAIN Initiative resource dissemination grant
U24NS113637.</p>
<section id="S21"><h3 class="pmc_sec_title">Funding Sources</h3>
<p id="P45">Research reported in this publication was also supported by the National
Institute Of Neurological Disorders And Stroke of the National Institutes of
Health under Award Number K23NS120037. The content is solely the responsibility
of the authors and does not necessarily represent the official views of the
National Institutes of Health.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title" data-anchor-id="fn-group1"><a id="fn-group1-anchor" data-anchor-id="fn-group1" class="usa-anchor"></a>Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="FN3">
<p id="P47">Conflict of Interest Statement</p>
<p id="P48">PAS has received investigational devices at no charge by Medtronic, Inc.
He also holds an educational grant to partially fund the UCSF Functional
Neurosurgery clinical fellowship from Medtronic, Inc. The other authors report
no potential conflicts of Interest.</p>
</div>
<div class="fn p" id="FN4">
<p id="P49">Statement of Ethics</p>
<p id="P50"><span class="text-underline">Study approval statement</span>: This study protocol was
reviewed and approved by the University of California Institutional Review
Board, study numbers 10-01350 and 10-02130.</p>
<p id="P51"><span class="text-underline">Consent to participate statement</span>: Written
informed consent was obtained from participants to participate in the study.</p>
</div>
</div></section><section id="S22"><h2 class="pmc_sec_title" data-anchor-id="S22"><a id="S22-anchor" data-anchor-id="S22" class="usa-anchor"></a>Data Availability Statement</h2>
<p id="P46">Data collected for this study will be made available upon request.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title" data-anchor-id="ref-list1"><a id="ref-list1-anchor" data-anchor-id="ref-list1" class="usa-anchor"></a>References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al. 
A randomized trial of deep-brain stimulation for
Parkinson’s disease. N Engl J Med
2006;355:896–908.
10.1056/NEJMoa060281.</cite> [<a href="https://doi.org/10.1056/NEJMoa060281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16943402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20randomized%20trial%20of%20deep-brain%20stimulation%20for%20Parkinson%E2%80%99s%20disease&amp;author=G%20Deuschl&amp;author=C%20Schade-Brittinger&amp;author=P%20Krack&amp;author=J%20Volkmann&amp;author=H%20Sch%C3%A4fer&amp;volume=355&amp;publication_year=2006&amp;pages=896-908&amp;pmid=16943402&amp;doi=10.1056/NEJMoa060281&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al. 
Bilateral deep brain stimulation vs best medical therapy for
patients with advanced Parkinson disease: a randomized controlled
trial. JAMA
2009;301:63–73.
10.1001/jama.2008.929.</cite> [<a href="https://doi.org/10.1001/jama.2008.929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2814800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19126811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Bilateral%20deep%20brain%20stimulation%20vs%20best%20medical%20therapy%20for%20patients%20with%20advanced%20Parkinson%20disease:%20a%20randomized%20controlled%20trial&amp;author=FM%20Weaver&amp;author=K%20Follett&amp;author=M%20Stern&amp;author=K%20Hur&amp;author=C%20Harris&amp;volume=301&amp;publication_year=2009&amp;pages=63-73&amp;pmid=19126811&amp;doi=10.1001/jama.2008.929&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. 
Pallidal versus subthalamic deep-brain stimulation for
Parkinson’s disease. N Engl J Med
2010;362:2077–91.
10.1056/NEJMoa0907083.</cite> [<a href="https://doi.org/10.1056/NEJMoa0907083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20519680/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Pallidal%20versus%20subthalamic%20deep-brain%20stimulation%20for%20Parkinson%E2%80%99s%20disease&amp;author=KA%20Follett&amp;author=FM%20Weaver&amp;author=M%20Stern&amp;author=K%20Hur&amp;author=CL%20Harris&amp;volume=362&amp;publication_year=2010&amp;pages=2077-91&amp;pmid=20519680&amp;doi=10.1056/NEJMoa0907083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. 
Deep brain stimulation plus best medical therapy versus best
medical therapy alone for advanced Parkinson’s disease (PD SURG
trial): a randomised, open-label trial. The Lancet Neurology
2010;9:581–91.
10.1016/s1474-4422(10)70093-4.</cite> [<a href="https://doi.org/10.1016/s1474-4422(10)70093-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2874872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20434403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Lancet%20Neurology&amp;title=Deep%20brain%20stimulation%20plus%20best%20medical%20therapy%20versus%20best%20medical%20therapy%20alone%20for%20advanced%20Parkinson%E2%80%99s%20disease%20(PD%20SURG%20trial):%20a%20randomised,%20open-label%20trial&amp;author=A%20Williams&amp;author=S%20Gill&amp;author=T%20Varma&amp;author=C%20Jenkinson&amp;author=N%20Quinn&amp;volume=9&amp;publication_year=2010&amp;pages=581-91&amp;pmid=20434403&amp;doi=10.1016/s1474-4422(10)70093-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Wharen RE Jr, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, et al. 
Thalamic DBS with a constant-current device in essential tremor:
A controlled clinical trial. Parkinsonism Relat Disord
2017;40:18–26.
10.1016/j.parkreldis.2017.03.017.</cite> [<a href="https://doi.org/10.1016/j.parkreldis.2017.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28400200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Parkinsonism%20Relat%20Disord&amp;title=Thalamic%20DBS%20with%20a%20constant-current%20device%20in%20essential%20tremor:%20A%20controlled%20clinical%20trial&amp;author=RE%20Wharen&amp;author=MS%20Okun&amp;author=BL%20Guthrie&amp;author=RJ%20Uitti&amp;author=P%20Larson&amp;volume=40&amp;publication_year=2017&amp;pages=18-26&amp;pmid=28400200&amp;doi=10.1016/j.parkreldis.2017.03.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, et al. 
Long-term suppression of tremor by chronic stimulation of the
ventral intermediate thalamic nucleus.
Lancet
1991;337:403–6.
10.1016/0140-6736(91)91175-t.</cite> [<a href="https://doi.org/10.1016/0140-6736(91)91175-t" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1671433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Long-term%20suppression%20of%20tremor%20by%20chronic%20stimulation%20of%20the%20ventral%20intermediate%20thalamic%20nucleus&amp;author=AL%20Benabid&amp;author=P%20Pollak&amp;author=C%20Gervason&amp;author=D%20Hoffmann&amp;author=DM%20Gao&amp;volume=337&amp;publication_year=1991&amp;pages=403-6&amp;pmid=1671433&amp;doi=10.1016/0140-6736(91)91175-t&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Schuurman PR, Richard Schuurman P, Andries Bosch D, Merkus MP, Speelman JD. Long-term follow-up of thalamic stimulation versus
thalamotomy for tremor suppression. Movement Disorders
2008;23:1146–53.
10.1002/mds.22059.</cite> [<a href="https://doi.org/10.1002/mds.22059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18442104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Movement%20Disorders&amp;title=Long-term%20follow-up%20of%20thalamic%20stimulation%20versus%20thalamotomy%20for%20tremor%20suppression&amp;author=PR%20Schuurman&amp;author=P%20Richard%20Schuurman&amp;author=D%20Andries%20Bosch&amp;author=MP%20Merkus&amp;author=JD%20Speelman&amp;volume=23&amp;publication_year=2008&amp;pages=1146-53&amp;pmid=18442104&amp;doi=10.1002/mds.22059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Vidailhet M, Vercueil L, Houeto J-L, Krystkowiak P, Benabid A-L, Cornu P, et al. 
Bilateral deep-brain stimulation of the globus pallidus in
primary generalized dystonia. N Engl J Med
2005;352:459–67.
10.1056/NEJMoa042187.</cite> [<a href="https://doi.org/10.1056/NEJMoa042187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15689584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Bilateral%20deep-brain%20stimulation%20of%20the%20globus%20pallidus%20in%20primary%20generalized%20dystonia&amp;author=M%20Vidailhet&amp;author=L%20Vercueil&amp;author=J-L%20Houeto&amp;author=P%20Krystkowiak&amp;author=A-L%20Benabid&amp;volume=352&amp;publication_year=2005&amp;pages=459-67&amp;pmid=15689584&amp;doi=10.1056/NEJMoa042187&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider G-H, Poewe W, et al. 
Pallidal deep-brain stimulation in primary generalized or
segmental dystonia. N Engl J Med
2006;355:1978–90.
10.1056/NEJMoa063618.</cite> [<a href="https://doi.org/10.1056/NEJMoa063618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17093249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Pallidal%20deep-brain%20stimulation%20in%20primary%20generalized%20or%20segmental%20dystonia&amp;author=A%20Kupsch&amp;author=R%20Benecke&amp;author=J%20M%C3%BCller&amp;author=T%20Trottenberg&amp;author=G-H%20Schneider&amp;volume=355&amp;publication_year=2006&amp;pages=1978-90&amp;pmid=17093249&amp;doi=10.1056/NEJMoa063618&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Kiss ZHT, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O, et al. 
The Canadian multicentre study of deep brain stimulation for
cervical dystonia. Brain
2007;130:2879–86.
10.1093/brain/awm229.</cite> [<a href="https://doi.org/10.1093/brain/awm229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17905796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=The%20Canadian%20multicentre%20study%20of%20deep%20brain%20stimulation%20for%20cervical%20dystonia&amp;author=ZHT%20Kiss&amp;author=K%20Doig-Beyaert&amp;author=M%20Eliasziw&amp;author=J%20Tsui&amp;author=A%20Haffenden&amp;volume=130&amp;publication_year=2007&amp;pages=2879-86&amp;pmid=17905796&amp;doi=10.1093/brain/awm229&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Ostrem JL, Racine CA, Glass GA, Grace JK, Volz MM, Heath SL, et al. 
Subthalamic nucleus deep brain stimulation in primary cervical
dystonia. Neurology
2011;76:870–8.
10.1212/WNL.0b013e31820f2e4f.</cite> [<a href="https://doi.org/10.1212/WNL.0b013e31820f2e4f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21383323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Subthalamic%20nucleus%20deep%20brain%20stimulation%20in%20primary%20cervical%20dystonia&amp;author=JL%20Ostrem&amp;author=CA%20Racine&amp;author=GA%20Glass&amp;author=JK%20Grace&amp;author=MM%20Volz&amp;volume=76&amp;publication_year=2011&amp;pages=870-8&amp;pmid=21383323&amp;doi=10.1212/WNL.0b013e31820f2e4f&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Habets JGV, Heijmans M, Kuijf ML, Janssen MLF, Temel Y, Kubben PL. An update on adaptive deep brain stimulation in
Parkinson’s disease. Mov Disord
2018;33:1834–43.
10.1002/mds.115.</cite> [<a href="https://doi.org/10.1002/mds.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6587997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30357911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mov%20Disord&amp;title=An%20update%20on%20adaptive%20deep%20brain%20stimulation%20in%20Parkinson%E2%80%99s%20disease&amp;author=JGV%20Habets&amp;author=M%20Heijmans&amp;author=ML%20Kuijf&amp;author=MLF%20Janssen&amp;author=Y%20Temel&amp;volume=33&amp;publication_year=2018&amp;pages=1834-43&amp;pmid=30357911&amp;doi=10.1002/mds.115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Little S, Brown P. The functional role of beta oscillations in
Parkinson’s disease. Parkinsonism Relat Disord
2014;20
Suppl 1:S44–8.
10.1016/S1353-8020(13)70013-0.</cite> [<a href="https://doi.org/10.1016/S1353-8020(13)70013-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24262186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Parkinsonism%20Relat%20Disord&amp;title=The%20functional%20role%20of%20beta%20oscillations%20in%20Parkinson%E2%80%99s%20disease&amp;author=S%20Little&amp;author=P%20Brown&amp;volume=20&amp;issue=Suppl%201&amp;publication_year=2014&amp;pages=S44-8&amp;pmid=24262186&amp;doi=10.1016/S1353-8020(13)70013-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Eisinger RS, Cernera S, Gittis A, Gunduz A, Okun MS. A review of basal ganglia circuits and physiology:
Application to deep brain stimulation. Parkinsonism Relat Disord
2019;59:9–20.
10.1016/j.parkreldis.2019.01.009.</cite> [<a href="https://doi.org/10.1016/j.parkreldis.2019.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7020857/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30658883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Parkinsonism%20Relat%20Disord&amp;title=A%20review%20of%20basal%20ganglia%20circuits%20and%20physiology:%20Application%20to%20deep%20brain%20stimulation&amp;author=RS%20Eisinger&amp;author=S%20Cernera&amp;author=A%20Gittis&amp;author=A%20Gunduz&amp;author=MS%20Okun&amp;volume=59&amp;publication_year=2019&amp;pages=9-20&amp;pmid=30658883&amp;doi=10.1016/j.parkreldis.2019.01.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Little S, Pogosyan A, Neal S, Zavala B, Zrinzo L, Hariz M, et al. 
Adaptive deep brain stimulation in advanced Parkinson
disease. Ann Neurol
2013;74:449–57.
10.1002/ana.23951.</cite> [<a href="https://doi.org/10.1002/ana.23951" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3886292/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23852650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol&amp;title=Adaptive%20deep%20brain%20stimulation%20in%20advanced%20Parkinson%20disease&amp;author=S%20Little&amp;author=A%20Pogosyan&amp;author=S%20Neal&amp;author=B%20Zavala&amp;author=L%20Zrinzo&amp;volume=74&amp;publication_year=2013&amp;pages=449-57&amp;pmid=23852650&amp;doi=10.1002/ana.23951&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Little S, Tripoliti E, Beudel M, Pogosyan A, Cagnan H, Herz D, et al. 
Adaptive deep brain stimulation for Parkinson’s disease
demonstrates reduced speech side effects compared to conventional
stimulation in the acute setting. Journal of Neurology, Neurosurgery &amp; Psychiatry
2016;87:1388–9.
10.1136/jnnp-2016-313518.</cite> [<a href="https://doi.org/10.1136/jnnp-2016-313518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5136720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27530809/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neurology,%20Neurosurgery%20&amp;%20Psychiatry&amp;title=Adaptive%20deep%20brain%20stimulation%20for%20Parkinson%E2%80%99s%20disease%20demonstrates%20reduced%20speech%20side%20effects%20compared%20to%20conventional%20stimulation%20in%20the%20acute%20setting&amp;author=S%20Little&amp;author=E%20Tripoliti&amp;author=M%20Beudel&amp;author=A%20Pogosyan&amp;author=H%20Cagnan&amp;volume=87&amp;publication_year=2016&amp;pages=1388-9&amp;pmid=27530809&amp;doi=10.1136/jnnp-2016-313518&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Velisar A, Syrkin-Nikolau J, Blumenfeld Z, Trager MH, Afzal MF, Prabhakar V, et al. 
Dual threshold neural closed loop deep brain stimulation in
Parkinson disease patients. Brain Stimul
2019;12:868–76.
10.1016/j.brs.2019.02.020.</cite> [<a href="https://doi.org/10.1016/j.brs.2019.02.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30833216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimul&amp;title=Dual%20threshold%20neural%20closed%20loop%20deep%20brain%20stimulation%20in%20Parkinson%20disease%20patients&amp;author=A%20Velisar&amp;author=J%20Syrkin-Nikolau&amp;author=Z%20Blumenfeld&amp;author=MH%20Trager&amp;author=MF%20Afzal&amp;volume=12&amp;publication_year=2019&amp;pages=868-76&amp;pmid=30833216&amp;doi=10.1016/j.brs.2019.02.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Piña-Fuentes D, van Zijl JC, van Dijk JMC, Little S, Tinkhauser G, Marinus Oterdoom DL, et al. 
The characteristics of pallidal low-frequency and beta bursts
could help implementing adaptive brain stimulation in the parkinsonian and
dystonic internal globus pallidus. Neurobiology of Disease
2019;121:47–57.
10.1016/j.nbd.2018.09.014.</cite> [<a href="https://doi.org/10.1016/j.nbd.2018.09.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30227227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiology%20of%20Disease&amp;title=The%20characteristics%20of%20pallidal%20low-frequency%20and%20beta%20bursts%20could%20help%20implementing%20adaptive%20brain%20stimulation%20in%20the%20parkinsonian%20and%20dystonic%20internal%20globus%20pallidus&amp;author=D%20Pi%C3%B1a-Fuentes&amp;author=JC%20van%20Zijl&amp;author=JMC%20van%20Dijk&amp;author=S%20Little&amp;author=G%20Tinkhauser&amp;volume=121&amp;publication_year=2019&amp;pages=47-57&amp;pmid=30227227&amp;doi=10.1016/j.nbd.2018.09.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Eusebio A, Thevathasan W, Doyle Gaynor L, Pogosyan A, Bye E, Foltynie T, et al. 
Deep brain stimulation can suppress pathological synchronisation
in parkinsonian patients. J Neurol Neurosurg Psychiatry
2011;82:569–73.
10.1136/jnnp.2010.217489.</cite> [<a href="https://doi.org/10.1136/jnnp.2010.217489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3072048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20935326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Neurosurg%20Psychiatry&amp;title=Deep%20brain%20stimulation%20can%20suppress%20pathological%20synchronisation%20in%20parkinsonian%20patients&amp;author=A%20Eusebio&amp;author=W%20Thevathasan&amp;author=L%20Doyle%20Gaynor&amp;author=A%20Pogosyan&amp;author=E%20Bye&amp;volume=82&amp;publication_year=2011&amp;pages=569-73&amp;pmid=20935326&amp;doi=10.1136/jnnp.2010.217489&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Opri E, Cernera S, Molina R, Eisinger RS, Cagle JN, Almeida L, et al. 
Chronic embedded cortico-thalamic closed-loop deep brain
stimulation for the treatment of essential tremor.
Science Translational Medicine
2020;12:eaay7680.
10.1126/scitranslmed.aay7680.</cite> [<a href="https://doi.org/10.1126/scitranslmed.aay7680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8182660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33268512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Translational%20Medicine&amp;title=Chronic%20embedded%20cortico-thalamic%20closed-loop%20deep%20brain%20stimulation%20for%20the%20treatment%20of%20essential%20tremor&amp;author=E%20Opri&amp;author=S%20Cernera&amp;author=R%20Molina&amp;author=RS%20Eisinger&amp;author=JN%20Cagle&amp;volume=12&amp;publication_year=2020&amp;pages=eaay7680&amp;pmid=33268512&amp;doi=10.1126/scitranslmed.aay7680&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Ostrem JL, Galifianakis NB, et al. 
Chronic multisite brain recordings from a totally implantable
bidirectional neural interface: experience in 5 patients with
Parkinson’s disease. J Neurosurg
2018;128:605–16.
10.3171/2016.11.JNS161162.</cite> [<a href="https://doi.org/10.3171/2016.11.JNS161162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5641233/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28409730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurosurg&amp;title=Chronic%20multisite%20brain%20recordings%20from%20a%20totally%20implantable%20bidirectional%20neural%20interface:%20experience%20in%205%20patients%20with%20Parkinson%E2%80%99s%20disease&amp;author=NC%20Swann&amp;author=C%20de%20Hemptinne&amp;author=S%20Miocinovic&amp;author=S%20Qasim&amp;author=JL%20Ostrem&amp;volume=128&amp;publication_year=2018&amp;pages=605-16&amp;pmid=28409730&amp;doi=10.3171/2016.11.JNS161162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Stanslaski S, Afshar P, Cong P, Giftakis J, Stypulkowski P, Carlson D, et al. 
Design and validation of a fully implantable, chronic,
closed-loop neuromodulation device with concurrent sensing and
stimulation. IEEE Trans Neural Syst Rehabil Eng
2012;20:410–21.
10.1109/TNSRE.2012.2183617.</cite> [<a href="https://doi.org/10.1109/TNSRE.2012.2183617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22275720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans%20Neural%20Syst%20Rehabil%20Eng&amp;title=Design%20and%20validation%20of%20a%20fully%20implantable,%20chronic,%20closed-loop%20neuromodulation%20device%20with%20concurrent%20sensing%20and%20stimulation&amp;author=S%20Stanslaski&amp;author=P%20Afshar&amp;author=P%20Cong&amp;author=J%20Giftakis&amp;author=P%20Stypulkowski&amp;volume=20&amp;publication_year=2012&amp;pages=410-21&amp;pmid=22275720&amp;doi=10.1109/TNSRE.2012.2183617&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Cummins DD, Kochanski RB, Gilron R, Swann NC, Little S, Hammer LH, et al. 
Chronic sensing of subthalamic local field potentials: Comparison
of first and second generation implantable bidirectional systems within a
single subject. Front Neurosci
2021;15:987. 10.3389/fnins.2021.725797.</cite> [<a href="https://doi.org/10.3389/fnins.2021.725797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8382799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34447294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neurosci&amp;title=Chronic%20sensing%20of%20subthalamic%20local%20field%20potentials:%20Comparison%20of%20first%20and%20second%20generation%20implantable%20bidirectional%20systems%20within%20a%20single%20subject&amp;author=DD%20Cummins&amp;author=RB%20Kochanski&amp;author=R%20Gilron&amp;author=NC%20Swann&amp;author=S%20Little&amp;volume=15&amp;publication_year=2021&amp;pages=987&amp;pmid=34447294&amp;doi=10.3389/fnins.2021.725797&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Neumann W-J, Staub-Bartelt F, Horn A, Schanda J, Schneider G-H, Brown P, et al. 
Long term correlation of subthalamic beta band activity with
motor impairment in patients with Parkinson’s
disease. Clinical Neurophysiology
2017;128:2286–91.
10.1016/j.clinph.2017.08.028.</cite> [<a href="https://doi.org/10.1016/j.clinph.2017.08.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5779610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29031219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Neurophysiology&amp;title=Long%20term%20correlation%20of%20subthalamic%20beta%20band%20activity%20with%20motor%20impairment%20in%20patients%20with%20Parkinson%E2%80%99s%20disease&amp;author=W-J%20Neumann&amp;author=F%20Staub-Bartelt&amp;author=A%20Horn&amp;author=J%20Schanda&amp;author=G-H%20Schneider&amp;volume=128&amp;publication_year=2017&amp;pages=2286-91&amp;pmid=29031219&amp;doi=10.1016/j.clinph.2017.08.028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Canessa A, Palmisano C, Isaias IU, Mazzoni A. Gait-related frequency modulation of beta oscillatory
activity in the subthalamic nucleus of parkinsonian
patients. Brain Stimul
2020;13:1743–52.
10.1016/j.brs.2020.09.006.</cite> [<a href="https://doi.org/10.1016/j.brs.2020.09.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32961337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimul&amp;title=Gait-related%20frequency%20modulation%20of%20beta%20oscillatory%20activity%20in%20the%20subthalamic%20nucleus%20of%20parkinsonian%20patients&amp;author=A%20Canessa&amp;author=C%20Palmisano&amp;author=IU%20Isaias&amp;author=A%20Mazzoni&amp;volume=13&amp;publication_year=2020&amp;pages=1743-52&amp;pmid=32961337&amp;doi=10.1016/j.brs.2020.09.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Dastin-van Rijn EM, Provenza NR, Calvert JS, Gilron R ‘ee, Allawala AB, Darie R, et al. 
Uncovering biomarkers during therapeutic neuromodulation with
PARRM: Period-based Artifact Reconstruction and Removal
Method. Cell Reports Methods
2021;1:100010. 10.1016/j.crmeth.2021.100010.</cite> [<a href="https://doi.org/10.1016/j.crmeth.2021.100010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8443190/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34532716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports%20Methods&amp;title=Uncovering%20biomarkers%20during%20therapeutic%20neuromodulation%20with%20PARRM:%20Period-based%20Artifact%20Reconstruction%20and%20Removal%20Method&amp;author=EM%20Dastin-van%20Rijn&amp;author=NR%20Provenza&amp;author=JS%20Calvert&amp;author=R%20%E2%80%98ee%20Gilron&amp;author=AB%20Allawala&amp;volume=1&amp;publication_year=2021&amp;pages=100010&amp;pmid=34532716&amp;doi=10.1016/j.crmeth.2021.100010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Stanslaski S, Herron J, Chouinard T, Bourget D, Isaacson B, Kremen V, et al. 
A Chronically Implantable Neural Coprocessor for Investigating
the Treatment of Neurological Disorders. IEEE Trans Biomed Circuits Syst
2018;12:1230–45.
10.1109/TBCAS.2018.2880148.</cite> [<a href="https://doi.org/10.1109/TBCAS.2018.2880148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6415546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30418885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans%20Biomed%20Circuits%20Syst&amp;title=A%20Chronically%20Implantable%20Neural%20Coprocessor%20for%20Investigating%20the%20Treatment%20of%20Neurological%20Disorders&amp;author=S%20Stanslaski&amp;author=J%20Herron&amp;author=T%20Chouinard&amp;author=D%20Bourget&amp;author=B%20Isaacson&amp;volume=12&amp;publication_year=2018&amp;pages=1230-45&amp;pmid=30418885&amp;doi=10.1109/TBCAS.2018.2880148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, et al. 
Long-term wireless streaming of neural recordings for circuit
discovery and adaptive stimulation in individuals with Parkinson’s
disease. Nature Biotechnology
2021. 10.1038/s41587-021-00897-5.</cite> [<a href="https://doi.org/10.1038/s41587-021-00897-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8434942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33941932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Biotechnology&amp;title=Long-term%20wireless%20streaming%20of%20neural%20recordings%20for%20circuit%20discovery%20and%20adaptive%20stimulation%20in%20individuals%20with%20Parkinson%E2%80%99s%20disease&amp;author=R%20Gilron&amp;author=S%20Little&amp;author=R%20Perrone&amp;author=R%20Wilt&amp;author=C%20de%20Hemptinne&amp;publication_year=2021&amp;pmid=33941932&amp;doi=10.1038/s41587-021-00897-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Jimenez-Shahed J
Device profile of the percept PC deep brain stimulation system
for the treatment of Parkinson’s disease and related
disorders. Expert Rev Med Devices
2021;18:319–32.
10.1080/17434440.2021.1909471.</cite> [<a href="https://doi.org/10.1080/17434440.2021.1909471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33765395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Med%20Devices&amp;title=Device%20profile%20of%20the%20percept%20PC%20deep%20brain%20stimulation%20system%20for%20the%20treatment%20of%20Parkinson%E2%80%99s%20disease%20and%20related%20disorders&amp;author=J%20Jimenez-Shahed&amp;volume=18&amp;publication_year=2021&amp;pages=319-32&amp;pmid=33765395&amp;doi=10.1080/17434440.2021.1909471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Goyal A, Goetz S, Stanslaski S, Oh Y, Rusheen AE, Klassen B, et al. 
The development of an implantable deep brain stimulation device
with simultaneous chronic electrophysiological recording and stimulation in
humans. Biosens Bioelectron
2021;176:112888. 10.1016/j.bios.2020.112888.</cite> [<a href="https://doi.org/10.1016/j.bios.2020.112888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7953342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33395569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biosens%20Bioelectron&amp;title=The%20development%20of%20an%20implantable%20deep%20brain%20stimulation%20device%20with%20simultaneous%20chronic%20electrophysiological%20recording%20and%20stimulation%20in%20humans&amp;author=A%20Goyal&amp;author=S%20Goetz&amp;author=S%20Stanslaski&amp;author=Y%20Oh&amp;author=AE%20Rusheen&amp;volume=176&amp;publication_year=2021&amp;pages=112888&amp;pmid=33395569&amp;doi=10.1016/j.bios.2020.112888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Neumann W-J, Memarian Sorkhabi M, Benjaber M, Feldmann LK, Saryyeva A, Krauss JK, et al. 
The sensitivity of ECG contamination to surgical implantation
site in brain computer interfaces. Brain Stimul
2021;14:1301–6.
10.1016/j.brs.2021.08.016.</cite> [<a href="https://doi.org/10.1016/j.brs.2021.08.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8460992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34428554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Stimul&amp;title=The%20sensitivity%20of%20ECG%20contamination%20to%20surgical%20implantation%20site%20in%20brain%20computer%20interfaces&amp;author=W-J%20Neumann&amp;author=M%20Memarian%20Sorkhabi&amp;author=M%20Benjaber&amp;author=LK%20Feldmann&amp;author=A%20Saryyeva&amp;volume=14&amp;publication_year=2021&amp;pages=1301-6&amp;pmid=34428554&amp;doi=10.1016/j.brs.2021.08.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Thenaisie Y, Palmisano C, Canessa A, Keulen BJ, Capetian P, Jiménez MC, et al. 
Towards adaptive deep brain stimulation: clinical and technical
notes on a novel commercial device for chronic brain
sensing. J Neural Eng
2021;18. 10.1088/1741-2552/ac1d5b.</cite> [<a href="https://doi.org/10.1088/1741-2552/ac1d5b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34388744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neural%20Eng&amp;title=Towards%20adaptive%20deep%20brain%20stimulation:%20clinical%20and%20technical%20notes%20on%20a%20novel%20commercial%20device%20for%20chronic%20brain%20sensing&amp;author=Y%20Thenaisie&amp;author=C%20Palmisano&amp;author=A%20Canessa&amp;author=BJ%20Keulen&amp;author=P%20Capetian&amp;publication_year=2021&amp;pages=18&amp;pmid=34388744&amp;doi=10.1088/1741-2552/ac1d5b&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Chen Y, Ma B, Hao H, Li L. Removal of Electrocardiogram Artifacts From Local Field
Potentials Recorded by Sensing-Enabled Neurostimulator.
Front Neurosci
2021;15:637274. 10.3389/fnins.2021.637274.</cite> [<a href="https://doi.org/10.3389/fnins.2021.637274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8071948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33912002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neurosci&amp;title=Removal%20of%20Electrocardiogram%20Artifacts%20From%20Local%20Field%20Potentials%20Recorded%20by%20Sensing-Enabled%20Neurostimulator&amp;author=Y%20Chen&amp;author=B%20Ma&amp;author=H%20Hao&amp;author=L%20Li&amp;volume=15&amp;publication_year=2021&amp;pages=637274&amp;pmid=33912002&amp;doi=10.3389/fnins.2021.637274&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Woody CD. Characterization of an adaptive filter for the analysis
of variable latency neuroelectric signals. Medical and Biological Engineering
1967;5:539–54.
10.1007/BF02474247.</cite> [<a href="https://doi.org/10.1007/BF02474247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medical%20and%20Biological%20Engineering&amp;title=Characterization%20of%20an%20adaptive%20filter%20for%20the%20analysis%20of%20variable%20latency%20neuroelectric%20signals&amp;author=CD%20Woody&amp;volume=5&amp;publication_year=1967&amp;pages=539-54&amp;doi=10.1007/BF02474247&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Goldberger AL, Goldberger ZD, Shvilkin A. Goldberger’s Clinical Electrocardiography: A Simplified Approach. 9th ed.
Elsevier; 2018; p.
7.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Goldberger%E2%80%99s%20Clinical%20Electrocardiography:%20A%20Simplified%20Approach&amp;author=AL%20Goldberger&amp;author=ZD%20Goldberger&amp;author=A%20Shvilkin&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Lu C, Amundsen Huffmaster SL, Louie KH, Sovell-Brown K, Vitek JL, MacKinnon CD, et al. 
Pallidal Oscillation Dynamics Following Cessation of Deep Brain
Stimulation in Parkinson’s Disease. Mov Disord
2020;35:1697–8.
10.1002/mds.28227.</cite> [<a href="https://doi.org/10.1002/mds.28227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7785860/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33400281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mov%20Disord&amp;title=Pallidal%20Oscillation%20Dynamics%20Following%20Cessation%20of%20Deep%20Brain%20Stimulation%20in%20Parkinson%E2%80%99s%20Disease&amp;author=C%20Lu&amp;author=SL%20Amundsen%20Huffmaster&amp;author=KH%20Louie&amp;author=K%20Sovell-Brown&amp;author=JL%20Vitek&amp;volume=35&amp;publication_year=2020&amp;pages=1697-8&amp;pmid=33400281&amp;doi=10.1002/mds.28227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Reck C, Florin E, Wojtecki L, Krause H, Groiss S, Voges J, et al. 
Characterisation of tremor-associated local field potentials in
the subthalamic nucleus in Parkinson’s disease.
Eur J Neurosci
2009;29:599–612.
10.1111/j.1460-9568.2008.06597.x.</cite> [<a href="https://doi.org/10.1111/j.1460-9568.2008.06597.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19187268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Neurosci&amp;title=Characterisation%20of%20tremor-associated%20local%20field%20potentials%20in%20the%20subthalamic%20nucleus%20in%20Parkinson%E2%80%99s%20disease&amp;author=C%20Reck&amp;author=E%20Florin&amp;author=L%20Wojtecki&amp;author=H%20Krause&amp;author=S%20Groiss&amp;volume=29&amp;publication_year=2009&amp;pages=599-612&amp;pmid=19187268&amp;doi=10.1111/j.1460-9568.2008.06597.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Patel B, Chiu S, Wong JK, Patterson A, Deeb W, Burns M, et al. 
Deep Brain Stimulation Programming Strategies: Segmented Leads,
Independent Current Sources and Future Technology.
Expert Rev Med Devices
2021. 10.1080/17434440.2021.1962286.</cite> [<a href="https://doi.org/10.1080/17434440.2021.1962286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34329566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Med%20Devices&amp;title=Deep%20Brain%20Stimulation%20Programming%20Strategies:%20Segmented%20Leads,%20Independent%20Current%20Sources%20and%20Future%20Technology&amp;author=B%20Patel&amp;author=S%20Chiu&amp;author=JK%20Wong&amp;author=A%20Patterson&amp;author=W%20Deeb&amp;publication_year=2021&amp;pmid=34329566&amp;doi=10.1080/17434440.2021.1962286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title" data-anchor-id="_ad93_"><a id="_ad93_-anchor" data-anchor-id="_ad93_" class="usa-anchor"></a>Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data collected for this study will be made available upon request.</p></section></section></section></section></article>